Company Profile for Axcella Health Inc.
September 24 2020 - 2:35PM
Business Wire
Axcella (Nasdaq: AXLA) is a clinical-stage biotechnology company
focused on leveraging endogenous metabolic modulators (EMMs) to
pioneer a new approach for treating complex diseases and improving
health. The company’s product candidates are comprised of EMMs and
their derivatives that are engineered in distinct combinations and
ratios to simultaneously impact multiple biological pathways.
Axcella’s pipeline includes lead therapeutic candidates for
non-alcoholic steatohepatitis (NASH) and the reduction in risk of
overt hepatic encephalopathy (OHE) recurrence. Additional muscle-
and blood-related programs are in earlier-stage development. For
more information, please visit www.axcellahealth.com.
Company:
Axcella Health Inc.
Headquarters Address:
840 Memorial Dr., Third Floor
CAMBRIDGE, MA 02139
Main Telephone:
857-320-2200
Website:
www.axcellahealth.com
Ticker:
AXLA(NASDAQ)
Type of Organization:
Public
Industry:
Biotechnology
Key Executives:
CEO: Bill Hinshaw
Investor Relations
Contact:
Jason Fredette
Phone:
7814240946
Email:
jfredette@axcellahealth.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200924005860/en/
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024